On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.
This is a PDF-only article. The first page of the PDF of this article appears above.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this Issue
May 1999, 22(5)
On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.
